| Maggie Hsin-i Lee, MD | |
|
1354 Chapel St, New Haven, CT 06511-4420 | |
| (203) 867-8300 | |
| (203) 867-5620 |
| Full Name | Maggie Hsin-i Lee |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Geriatric Medicine |
| Location | 1354 Chapel St, New Haven, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609001551 | NPI | - | NPPES |
| Entity Name | Whc Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700154226 PECOS PAC ID: 6103093513 Enrollment ID: O20120125000252 |
News Archive
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Patients with acutely life-threatening health conditions who were treated in the innovative Critical Care Resuscitation Unit received faster treatment and had better health outcomes, including a 36 percent lower risk of dying than those who were transferred from a hospital's emergency department then evaluated and treated in a traditional intensive care unit, according to a recent study in the Journal of Emergency Medicine conducted by researchers at the University of Maryland School of Medicine.
"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
New cutting-edge research undertaken at the University of Leicester could revolutionize the way new drugs are developed and the way patients are cared for, through a pioneering new approach using virtual clinical trials
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maggie Hsin-i Lee, MD Po Box 415126, Boston, MA 02241-5126 Ph: (203) 867-8300 | Maggie Hsin-i Lee, MD 1354 Chapel St, New Haven, CT 06511-4420 Ph: (203) 867-8300 |
News Archive
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Patients with acutely life-threatening health conditions who were treated in the innovative Critical Care Resuscitation Unit received faster treatment and had better health outcomes, including a 36 percent lower risk of dying than those who were transferred from a hospital's emergency department then evaluated and treated in a traditional intensive care unit, according to a recent study in the Journal of Emergency Medicine conducted by researchers at the University of Maryland School of Medicine.
"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
New cutting-edge research undertaken at the University of Leicester could revolutionize the way new drugs are developed and the way patients are cared for, through a pioneering new approach using virtual clinical trials
› Verified 8 days ago
Joel Daniel Newman Bluman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Obinna Anosike, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4444 | |
Rebecca Arnold, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Cedar St, New Haven, CT 06510 Phone: 719-237-9972 | |
Dr. Dorothyann J Van Rhijn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 55 Lock Street, New Haven, CT 06520 Phone: 203-432-0076 Fax: 203-432-7289 | |
Dr. Kyle Elligers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Hadrian Holder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 428 Columbus Avenue, New Haven, CT 06519 Phone: 203-503-3000 Fax: 203-503-3224 | |
Dr. Ashley L Demory, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 |